These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 33417675)
1. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice. Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675 [TBL] [Abstract][Full Text] [Related]
2. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation. Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury. Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825 [TBL] [Abstract][Full Text] [Related]
5. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523 [TBL] [Abstract][Full Text] [Related]
6. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150 [TBL] [Abstract][Full Text] [Related]
7. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling. Qiu Y; Yu J; Li Y; Yang F; Yu H; Xue M; Zhang F; Jiang X; Ji X; Bao Z Ann Med; 2021 Dec; 53(1):508-522. PubMed ID: 33783283 [No Abstract] [Full Text] [Related]
9. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. Xu H; Fang F; Wu K; Song J; Li Y; Lu X; Liu J; Zhou L; Yu W; Yu F; Gao J Microbiome; 2023 Nov; 11(1):262. PubMed ID: 38001551 [TBL] [Abstract][Full Text] [Related]
10. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same. Sitkin S; Pokrotnieks J Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190 [TBL] [Abstract][Full Text] [Related]
11. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Dong S; Zhu M; Wang K; Zhao X; Hu L; Jing W; Lu H; Wang S Pharmacol Res; 2021 Sep; 171():105767. PubMed ID: 34273490 [TBL] [Abstract][Full Text] [Related]
12. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis. Li H; Xi Y; Xin X; Tian H; Hu Y Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416 [TBL] [Abstract][Full Text] [Related]
13. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887 [TBL] [Abstract][Full Text] [Related]
14. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice. Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464 [TBL] [Abstract][Full Text] [Related]
15. FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid. Friedman ES; Li Y; Shen TD; Jiang J; Chau L; Adorini L; Babakhani F; Edwards J; Shapiro D; Zhao C; Carr RM; Bittinger K; Li H; Wu GD Gastroenterology; 2018 Dec; 155(6):1741-1752.e5. PubMed ID: 30144429 [TBL] [Abstract][Full Text] [Related]
16. Microbiota-induced obesity requires farnesoid X receptor. Parséus A; Sommer N; Sommer F; Caesar R; Molinaro A; Ståhlman M; Greiner TU; Perkins R; Bäckhed F Gut; 2017 Mar; 66(3):429-437. PubMed ID: 26740296 [TBL] [Abstract][Full Text] [Related]
17. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice. Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192 [TBL] [Abstract][Full Text] [Related]
18. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice. He B; Jiang J; Shi Z; Wu L; Yan J; Chen Z; Luo M; Cui D; Xu S; Yan M; Zhang S; Chen Z Biomed Pharmacother; 2021 Mar; 135():111183. PubMed ID: 33401222 [TBL] [Abstract][Full Text] [Related]
19. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. Chen J; Thomsen M; Vitetta L J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932 [TBL] [Abstract][Full Text] [Related]
20. The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease. Zhang DY; Zhu L; Liu HN; Tseng YJ; Weng SQ; Liu TT; Dong L; Shen XZ Drug Des Devel Ther; 2019; 13():2249-2270. PubMed ID: 31308634 [No Abstract] [Full Text] [Related] [Next] [New Search]